Login / Signup
Sen Xu
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Pi K Akt
Lymph Node
Locally Advanced
Dna Repair
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ping Jin
,
Xin Li
,
Yu Xia
,
Hua-Yi Li
,
Xiaoting Li
,
Zong-Yuan Yang
,
Zhen Wang
,
Cheng Xu
,
Tian Fang
,
Dongchen Zhou
,
Xiaoming Xiong
,
Si-Yuan Wang
,
Sen Xu
,
Qing-Lei Gao
Bepotastine sensitizes ovarian cancer to PARP inhibitors through suppressing NF-κB-triggered SASP in cancer-associated fibroblasts.
Molecular cancer therapeutics
(2023)